Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allergan Aesthetics, a subsidiary of AbbVie, is a global leader in medical aesthetics, developing and manufacturing a diverse portfolio of products designed to address various aesthetic concerns. The company's flagship product, Botox Cosmetic, is the world's leading neurotoxin for the temporary improvement of facial lines. Beyond neurotoxins, the company offers the Juvéderm collection of dermal fillers, the CoolSculpting body contouring system, and the SkinMedica professional skincare line. Allergan Aesthetics focuses on evidence-based treatments and continues to invest in research and development to expand its pipeline of minimally invasive aesthetic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aesthetics.